World News | US Development Finance Corporation chief Marchick to visit India
Washington [US], October 16 (ANI): David Marchick, Chief Operating Officer (COO) of the United States’ International Development Finance Corporation (DFC), will travel to India from October 24-26 with the aim of advancing DFC investments to boost global health and expand COVID-19 vaccine production capacity.
âCOO Marchick and the traveling delegation will arrive in India on October 24, 2021. In Hyderabad, the delegation will visit the offices of Biological E, the Indian vaccine maker, and participate in a signing ceremony to open a new facility with substantial capacity for manufacture of vaccines. This work supports the historic commitment made by President Biden and his âQuadâ counterparts – Australia, India, Japan and the United States, âthe DFC media advisory read.
Read also | IMF welcomes India’s “swift and substantial” response to the COVID-19 pandemic.
Marchick is also due to travel to South Africa. His visit to the two countries is scheduled to begin on October 18 and end in India on October 26.
DFC’s vice president of development credit Jim Polan and other senior DFC executives will accompany the chief operating officer, the press release said.
Read also | Bangladesh Violence: ISKCON temple vandalized in Nakhali, 1 killed, 17 injured.
While in South Africa, the DFC delegation will visit Data Centers in Africa, a DFC client that is developing and expanding critical technology infrastructure across Africa.
“The delegation will visit the sterile facilities of Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer, in Gqeberha (formerly Port Elizabeth), and meet with other manufacturers of pharmaceuticals critical to the COVID-19 response,” added the media advisory. Â»Media advisory
The DFC media advisory noted that since day one of the Biden administration, “President Biden has said the only way to defeat COVID-19 is to end the pandemic both at home and abroad. ‘abroad by vaccinating Americans at home and non-Americans abroad. “
So far, the United States has pledged to donate 1.1 billion doses of vaccine and has already shipped nearly 200 million doses to developing countries – “more doses than the rest of the world combined.” .
DFC’s financial tools are driving growth in vaccine manufacturing capacity in multiple regions, with multiple technologies and in countries large and small, according to the advisory.
Already, DFC’s support is expected to facilitate the expansion of capacity to produce nearly 2 billion doses of COVID-19 vaccine worldwide by the end of 2022, with other projects underway.
The agency is also working to expand access to essential treatments and introduce medical equipment designed for low-resource environments as part of the Global CFD Health and Welfare Initiative, the advisory added. (ANI)
(This is an unedited and auto-generated story from the syndicated news feed, the staff at LatestLY may not have edited or edited the body of the content)